GRPR and neoplasm: Thus, in [30] it was shown by Liolios et al. that bispecific PSMA/GRPr conjugate containing (HE)2-tag showed significantly higher tumor/healthy tissue ratio in in vivo LNCaP tumor models than its (HE)3-, (HE)1- and (HE)0-tag analogues.